ArtiSential® for Rectal Cancer Surgery

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Rectal Cancer

Treatments

Device: ArtiSential®

Study type

Observational

Funder types

Other

Identifiers

NCT06236282
2208-0071346

Details and patient eligibility

About

This study aimed to assess efficacy of ArtiSential® in reducing laparoscopic rectal cancer surgery duration. We retrospectively reviewed the data of patients who underwent laparoscopic low or ultralow anterior resection for primary mid-to-low rectal cancer, performed by a single surgeon in 2012-2022. Patients were divided into groups, use group vs. non-use group, based on the use or non-use of the ArtiSential®. The total mesorectal excision quality and resection margin status did not differ between the groups. ArtiSential® reduced operative time without impairing surgical quality or oncologic outcomes.

Enrollment

93 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • mid-to-low rectal caner (witing 10cm of the anal verge)
  • laparoscopic surgery

Exclusion criteria

  • combined surgery
  • recurrent rectal cancer surgery

Trial design

93 participants in 2 patient groups

ArtiSential® Use
Description:
Laparoscopic low anterior resection, with use of both straight devices and articulated devices
Treatment:
Device: ArtiSential®
ArtiSential® Non-Use
Description:
Laparoscopic low anterior resection, with use of straight devices only

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems